PRESS RELEASE published on 02/20/2025 at 18:30, 1 year 1 month ago Inside Information / Operations of the issuer (acquisitions, sales...) Theraclion secures financing of €6 million through a convertible bond loan with firm commitments from historical shareholders, Furui and Unigestion. CEO Martin Deterre highlights strategic priorities for revenue growth and FDA approval Financing Strategic Priorities FDA Approval Theraclion Convertible Bond Loan
PRESS RELEASE published on 02/20/2025 at 18:30, 1 year 1 month ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...) Theraclion sécurise un financement de 6 millions d'euros auprès de ses actionnaires historiques grâce à un emprunt obligataire convertible. Objectif : poursuite R&D et développement commercial Actionnaires Financement Emprunt Theraclion Obligataire Convertible
BRIEF published on 02/07/2025 at 18:35, 1 year 1 month ago Publication des comptes ajustés de Theraclion pour le premier semestre 2024 Trésorerie Theraclion Comptes Ajustés Ultrasons Focalisés Marche Des Varices
BRIEF published on 02/07/2025 at 18:35, 1 year 1 month ago Publication of Theraclion's adjusted accounts for the first half of 2024 Treasury Theraclion Adjusted Accounts Focused Ultrasound Varicose Veins Walk
PRESS RELEASE published on 02/07/2025 at 18:30, 1 year 1 month ago Informations privilégiées / Communiqué sur comptes, résultats Publication des comptes ajustés du premier semestre 2024 de Theraclion, société innovante en thérapie ultrasonique pour varices. Focus sur recentrage stratégique et résultats financiers Stratégie Résultats Financiers Theraclion Varices Comptes Ajustés
BRIEF published on 01/06/2025 at 19:06, 1 year 2 months ago Theraclion 2024 Review: Progress and Challenges Turnover Theraclion SONOVEIN® FDA Clinical Trial Product Maturity
BRIEF published on 01/06/2025 at 19:06, 1 year 2 months ago Bilan 2024 de Theraclion : avancées et défis Chiffre D'affaires Theraclion SONOVEIN® Essai Clinique FDA Maturité Produit
PRESS RELEASE published on 01/06/2025 at 19:01, 1 year 2 months ago Informations privilégiées / Communiqué sur comptes, résultats THERACLION fait le bilan de ses réalisations en 2024, mettant en avant les avancées de son essai clinique pivot FDA et la maturité de son produit SONOVEIN® pour traitement des varices 2024 Essai Clinique Theraclion SONOVEIN® Varices
BRIEF published on 10/30/2024 at 19:05, 1 year 4 months ago Theraclion: Results for the First Half of 2024 and Strategic Outlook Financial Results Theraclion SONOVEIN FDA America Marketing 2025
BRIEF published on 10/30/2024 at 19:05, 1 year 4 months ago Theraclion : Résultats du Premier Semestre 2024 et Perspectives Stratégiques Résultats Financiers Theraclion SONOVEIN FDA Amérique Commercialisation 2025
Published on 03/23/2026 at 14:05, 3 hours 58 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 4 hours 3 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 4 hours 58 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 5 hours 31 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 5 hours 33 minutes ago Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 17:54, 8 minutes ago EQS-Adhoc: net digital AG publishes 2026 forecast with continued growth in revenue and earnings
Published on 03/23/2026 at 17:45, 17 minutes ago Carvolix joins key Euronext indices, marking a new milestone in its capital markets profile.
Published on 03/23/2026 at 17:45, 17 minutes ago Carvolix rejoint des indices clés d’Euronext, marquant une nouvelle étape dans son positionnement sur les marchés financiers.
Published on 03/23/2026 at 17:44, 18 minutes ago Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH): Buy
Published on 03/23/2026 at 17:00, 1 hour 2 minutes ago Phuket consolide sa position privilégiée pour les familles du monde entier en quête d’un lieu de résidence sûr
Published on 03/23/2026 at 17:45, 17 minutes ago ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 17 minutes ago En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde
Published on 03/23/2026 at 17:45, 18 minutes ago Share buyback for allocation to employees or corporate officers
